A 73-year-old woman with rosacea, who had started treatment with erythromycin stearate 2 g/d, developed asymptomatic liver injury. The drug was discontinued and the laboratory findings of liver damage disappeared within 11 days. This is the first report of erythromycin stearate-induced asymptomatic hepatotoxicity.
ShellyWBJuhlinL. A new test for detecting anaphylactic sensitivity: the basophil reaction. Nature1961; 191: 1056–8.
8.
FarmerCDHoffmanHNShorterRGThurberDLBartholomewLG. Intrahepatic cholestasis associated with the ingestion of erythromycin estolate. Gastroenterology1963; 45: 157–60.
